Hepatitis B y enfermedad celíaca: ¿un motivo de preocupación?
DOI:
https://doi.org/10.22516/25007440.1016Palabras clave:
Hepatitis B, Enfermedad celiaca, Interferón-alfa, VacunasResumen
Algunas teorías sugieren que el desarrollo de la respuesta inmunitaria para la eliminación de la hepatitis B desencadena el daño del tejido intestinal observado en la enfermedad celíaca en individuos genéticamente predispuestos. Aunque el papel de la infección por el virus de la hepatitis B en el desarrollo de enfermedades autoinmunes se ha discutido ampliamente en la literatura, sigue siendo un tema controvertido. Nuestro objetivo es revisar si existe una asociación entre la hepatitis B y la enfermedad celíaca y las particularidades de la vacunación contra la hepatitis B en pacientes celíacos.
Descargas
Referencias bibliográficas
Freeman HJ. Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms. Gut and liver. 2015;9(1):28-37. https://doi.org/10.5009/gnl14288
Green PH, Jabri B. Coeliac disease. Lancet. 2003;362(9381):383-91. https://doi.org/10.1016/S0140-6736(03)14027-5
Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9(3):318-30. https://doi.org/10.1016/S1474-4422(09)70290-X
Yoosuf S, Singh P, Khaitan A, Strand T, Ahuja V, Makharia GK. Prevalence of celiac disease in patients with liver diseases: a systematic review and meta-analyses. Am J Gastroenterol. 2023;118(5):820-32. https://doi.org/10.14309/ajg.0000000000002123
Kumar V, Jarzabek-Chorzelska M, Sulej J, Karnewska K, Farrell T, Jablonska S. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol. 2002;9(6):1295-300. https://doi.org/10.1128/CDLI.9.6.1295-1300.2002
Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105(12):2520-4. https://doi.org/10.1038/ajg.2010.276
Marsh MN. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology. 1992;102(1):330-54. https://doi.org/10.1016/0016-5085(92)91819-P
Narciso-Schiavon JL, Schiavon LL. To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol. 2017;23(5):776-91. https://doi.org/10.3748/wjg.v23.i5.776
Narciso-Schiavon JL, Schiavon LL. Celiac disease screening in patients with cryptogenic cirrhosis. World J Gastroenterol. 2023;29(2):410-2. https://doi.org/10.3748/wjg.v29.i2.410
World Health Organization (WHO). Hepatitis B vaccines: WHO position paper; 2017. Wkly Epidemiol Rec. 2017;92(27):369-92.
Leonardi S, La Rosa M. Are hepatitis B virus and celiac disease linked? Hepat Mon. 2010;10(3):173-5.
Sima H, Hekmatdoost A, Ghaziani T, Alavian SM, Mashayekh A, Zali MR. The prevalence of celiac autoantibodies in hepatitis patients. Iran J Allergy Asthma Immunol. 2010;9(3):157-62.
Nau AL, Fayad L, Lazzarotto C, Shiozawa MB, Dantas-Corrêa EB, Schiavon LL, et al. Prevalence and clinical features of celiac disease in patients with hepatitis B virus infection in Southern Brazil. Rev Soc Bras Med Trop. 2013;46(4):397-402. https://doi.org/10.1590/0037-8682-0093-2013
Sood A, Khurana MS, Mahajan R, Midha V, Puri S, Kaur A, et al. Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease. J Gastroenterol Hepatol. 2017;32(2):446-50. https://doi.org/10.1111/jgh.13474
Tursi A. Celiac disease and viral B hepatitis: lessons for clinical practice. Hepat Mon. 2010;10(4):311-2.
Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol. 2009;81(12):1999-2006. https://doi.org/10.1002/jmv.21643
Gasbarrini G, Miele L, Malandrino N, Grieco A, Addolorato G, Gasbarrini A, Cammarota G, Bonvicini F. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol. 2009;22(1):1-7. https://doi.org/10.1177/039463200902200101
Corrêa WK. Considerações sobre a formação territorial e econômica de Santa Catarina. Geosul. 1999;14(27):25-44.
Soto Iglesias S, Vazquez Rodriguez S, Ulla Rocha JL, Baltar Arias R, Diaz Saa W, Barrio Antoranz J, et al. [Onset of celiac disease after acute hepatitis B infection]. Gastroenterol Hepatol. 2010;33(1):17-20. https://doi.org/10.1016/j.gastrohep.2009.06.005
Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology. 1995;22(3):833-6.
Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur. J. Gastroenterol. Hepatol. 1999;11(3):283-8. https://doi.org/10.1097/00042737-199903000-00012
Moghaddam MA, Rostami Nejad M, Shalmani HM, Rostami K, Nazemalhosseini Mojarad E, Aldulaimi D, et al. The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease. Int J Prev Med. 2013;4(6):700-4.
Tanwar A, Gupta GK, Chauhan V, Sharma D, Jain MK, Bhardwaj H, et al. Celiac Disease and Portal Hypertension: A Causal Association or Just a Coincidence? J Clin Exp Hepatol. 2020;10(4):290-5. https://doi.org/10.1016/j.jceh.2019.11.005
Ye J, Chen J. Interferon and Hepatitis B: Current and Future Perspectives. Front Immunol. 2021;12:733364. https://doi.org/10.3389/fimmu.2021.733364
Bardella MT, Marino R, Meroni PL. Celiac disease during interferon treatment. Ann Intern Med. 1999;131(2):157-8. https://doi.org/10.7326/0003-4819-131-2-199907200-00024
Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of celiac disease during treatment with Interferon for chronic hepatitis C. Lancet. 2000;356(9240):1494-5. https://doi.org/10.1016/S0140-6736(00)02880-4
Adinolfi LE, Durante Mangoni E, Andreana A. Interferon and Ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterology. 2001;96(2):607-8. https://doi.org/10.1111/j.1572-0241.2001.03574.x
Monteleone G, Pender SL, Alstead E, Hauer AC, Lionetti P, McKenzie C, et al. Role of interferon α in promoting T helper cell type 1 responses in the small intestine in celiac disease. Gut. 2001;48(3):425-9. https://doi.org/10.1136/gut.48.3.425
Narvaes I, Belen P, Mar Alcalde M, Jimenez C, Soria A. Chronic viral hepatitis, Interferon, diabetes mellitus, and celiac disease. Am J Gastroenterol. 2003;98(10):2336-7. https://doi.org/10.1111/j.1572-0241.2003.07652.x
Shaw Jr FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7(5):425-30. https://doi.org/10.1016/0264-410X(89)90157-6
Treadwell TL, Keeffe EB, Lake J, Read A, Friedman LS, Goldman IS, et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med. 1993;95(6):584-8. https://doi.org/10.1016/0002-9343(93)90353-Q
Romano L, Zanetti AR. Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements. Viruses. 2022;14(7):1515. https://doi.org/10.3390/v14071515
Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine. 2009;27(43):6030-3. https://doi.org/10.1016/j.vaccine.2009.07.099
Nemes E, Lefler E, Szegedi L, Kapitany A, Kovacs JB, Balogh M, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121(6):e1570-6. https://doi.org/10.1542/peds.2007-2446
Ahishali E, Boztas G, Akyuz F, Ibrisim D, Poturoglu S, Pinarbasi B, et al. Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci. 2008;53(8):2156-9. https://doi.org/10.1007/s10620-007-0128-3
Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44(4):431-5. https://doi.org/10.1097/MPG.0b013e3180320654
Belloni C, Avanzini MA, De Silvestri A, Martinetti M, Pasi A, Coslovich E, et al. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine. Pediatrics. 2002;110(1 Pt 1):e4. https://doi.org/10.1542/peds.110.1.e4
Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens. 1998;51(6):593-604. https://doi.org/10.1111/j.1399-0039.1998.tb03001.x
Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989;321(11):708-12. https://doi.org/10.1056/NEJM198909143211103
Trovato CM, Montuori M, Sansone A, Morelli A, Russo G, Pietropaoli N, et al. Association between Elevated TGA-IgA Titers and Older Age at Diagnosis with Absence of HBV Seroconversion in Celiac Children. Vaccines (Basel). 2021;9(2):101. https://doi.org/10.3390/vaccines9020101
Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoglu E, et al. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol. 2010;22(7):787-93. https://doi.org/10.1097/MEG.0b013e32832e9d41
Rousseff T, Claeys T, Vande Vijver E, Moes N, Vande Velde S, Schelstraete P, et al. Hepatitis B virus vaccination and revaccination response in children diagnosed with coeliac disease: a multicentre prospective study. Acta Gastroenterol Belg. 2019;82(1):27-30.
Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, Rosa ML. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol. 2012;18(40):5729-33. https://doi.org/10.3748/wjg.v18.i40.5729
Sangfelt P, Uhnoo I, Reichard O, Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol. 2008;43(4):465-72. https://doi.org/10.1080/00365520701733806
Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow. World J Gastroenterol 2013;19(6):838-45. https://doi.org/10.3748/wjg.v19.i6.838
Zingone F, Morisco F, Zanetti A, Romanò L, Portella G, Capone P, et al. Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine. 2011;29(5):1005-8. https://doi.org/10.1016/j.vaccine.2010.11.060
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Revista colombiana de Gastroenterología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
